← Open Payments lookup

HALLIE CARTER: Open Payments

NPI 1770103053 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,113 in 65 payments from 10 companies in 2025. Trend: 2023 $619 · 2024 $500 · 2025 $1,113

Food & beverage: $1,113
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$453
ABBVIE INC.19$156
Supernus Pharmaceuticals, Inc.5$101
Vanda Pharmaceuticals Inc.3$81
E.R. Squibb & Sons, L.L.C.3$76
Axsome Therapeutics, Inc.3$73
Otsuka America Pharmaceutical, Inc.2$59
Janssen Pharmaceuticals, Inc3$58
Takeda Pharmaceuticals U.S.A., Inc.2$38
Lundbeck LLC1$20

Products named: CAPLYTA, VRAYLAR, Qelbree, FANAPT, REXULTI, COBENFY, Auvelity, SPRAVATO.

Industry payments across MS — which companies pay providers there.